Urgent: Hydroxycut Suits Have Already Been Entered
Sunday, June 28th, 2009On May 1, 2009, there was a recall of fourteen Hydroxycut diet-aid products stemming from a number of reports that people using the products were developing major liver issues and other health issues. Less than seven days later, on May four, the 1st Hydroxycut class action lawsuit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Lawsuit alleges company laxity in informing the public about potential hazards of the products. Naturally, it’s too shortly to know how the suit is going to turn out, but if the company had information which it didn’t divulge to buyers, it should definitely be held accountable.
A class action court action is filed by a group of folks, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less dear, than filing an individual suit. As a rule, filing a class action legal action will not cost you anything unless there’s a settlement. At that point, the attorney who handled the suit will take his fees from the compensation that was awarded and then share the remaining funds to the litigants in the case. Since this is the case, you will be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is an example of the reasons that class action lawsuits have become so popular.
The 1st class action lawsuit against Iovate was filed in Canada where the company is located and represents all Canadian citizens who sustained health problems due to Hydroxycut products. The FDA recall happened in the U. S. where twenty-three cases of liver disorders and other health issues had been reported. Health Canada did not receive any reports of liver damage due to the diet products, but they did receive 17 reports concerning folks who sustained breathing, neurological, cardio, and stomach problems as a consequence of Canadians using the products.
The Hydroxycut Lawsuits alleges the company sold the products without correctly informing the general public of the public of the health risks that they could exposing buyers to. The complaint states the company failed to publish the information on the product labels saying that users could run the risk of liver and kidney damage as well as gut, cardio, respiratory, and neurological issues. The suit goes on to claim this was an obvious omission on the part of the company which deliberately misled clients concerning the security of the products.
